INVO Fertility, Inc. (IVF)

INVO Fertility Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023
Net Income	-27.94	-9.1	-8.03
Depreciation & Amortization	0.87	0.92	0.2
Other Amortization	0.4	0.62	0.72
Loss (Gain) From Sale of Assets	1.53	0.51	-
Loss (Gain) From Sale of Investments	-	-	0.09
Loss (Gain) on Equity Investments	0.01	-0.01	0.06
Stock-Based Compensation	1.21	1.77	1.57
Other Operating Activities	0.42	0.44	0.16
Change in Accounts Receivable	0.01	-0.03	-0.06
Change in Inventory	0.04	0.04	-0
Change in Accounts Payable	0.63	1.35	0.92
Change in Unearned Revenue	0.42	0.19	0.29
Change in Other Net Operating Assets	-0.16	0.31	-0.68
Operating Cash Flow	-6.52	-2.97	-4.76
Capital Expenditures	-0.1	-0.18	-0.44
Sale of Property, Plant & Equipment	-	0.08	-
Cash Acquisitions	0.47	0.47	-2.04
Investment in Securities	-	-	-0.01
Investing Cash Flow	0.36	0.36	-2.49
Short-Term Debt Issued	-	-	0.1
Long-Term Debt Issued	-	1.34	3.06
Total Debt Issued	0.9	1.34	3.16
Long-Term Debt Repaid	-	-0.93	-1.5
Net Debt Issued (Repaid)	-0.65	0.41	1.66
Issuance of Common Stock	9.77	1.07	5.73
Financing Cash Flow	5.76	3.12	7.39
Net Cash Flow	-0.39	0.51	0.14
Free Cash Flow	-6.62	-3.16	-5.2
Free Cash Flow Margin	-100.06%	-48.35%	-172.14%
Free Cash Flow Per Share	-31.53	-30.61	-130.80
Cash Interest Paid	0.39	0.21	0.01
Levered Free Cash Flow	-	3.2	-
Unlevered Free Cash Flow	-	3.24	-
Change in Working Capital	0.94	1.86	0.47

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q